| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 83386 |
(S,R,S)-AHPC-C6-NH2(dihydrochloride),2341796-77-6 |
178 |
h |
2024-12-23 |
| 83387 |
Cl-C6-PEG12-NH2 hydrochloride |
156 |
h |
2024-12-23 |
| 83388 |
DiA荧光控制甘露糖基氯膦酸盐脂质体,DiA Fluorescent Control Mannosylated Clodronate Liposomes |
230 |
axc |
2024-12-23 |
| 83389 |
Cl-C6-PEG1-NH2 hydrochloride,氯-C6-一聚乙二醇-氨基盐酸盐 |
186 |
h |
2024-12-23 |
| 83390 |
DiO荧光控制甘露糖基氯膦酸盐脂质体,DiO Fluorescent Control Mannosylated Clodronate Liposomes |
151 |
axc |
2024-12-23 |
| 83391 |
Cl-C6-PEG5-NH2 hydrochloride,2241669-16-7 |
216 |
h |
2024-12-23 |
| 83392 |
DiI荧光控制甘露糖基氯膦酸盐脂质体,DiI Fluorescent Control Mannosylated Clodronate Liposomes |
206 |
axc |
2024-12-23 |
| 83393 |
Cl-C6-PEG4-NH2 hydrochloride,1261238-20-3 |
216 |
h |
2024-12-23 |
| 83394 |
DiR Fluorescent Control Liposomes (Anionic),DiR荧光控制脂质体(阴离子) |
211 |
axc |
2024-12-23 |
| 83395 |
Amino-PEG11-C6 (HCl salt),氨基-PEG11-C6 (HCl salt) |
145 |
h |
2024-12-23 |
| 83396 |
DiR Fluorescent Control Liposomes (Neutral) ,DiR荧光控制脂质体(中性) |
197 |
axc |
2024-12-23 |
| 83397 |
Cl-C6-PEG6-O-CH2COOH,氯-C6-六聚乙二醇-O-乙酸 |
179 |
h |
2024-12-23 |
| 83398 |
Cl-C6-PEG2-O-CH2COOH,2245697-88-3 |
146 |
h |
2024-12-23 |
| 83399 |
5-TAMRA-C6-azide,1006592-61-5 |
175 |
h |
2024-12-23 |
| 83400 |
DiD Fluorescent Control Liposomes (Anionic) ,荧光控制脂质体(阴离子) |
196 |
axc |
2024-12-23 |
| 83401 |
Amino-PEG4-C6 (HCl salt),3024055-45-3 |
195 |
h |
2024-12-23 |
| 83402 |
Amino-PEG7-C6 (HCl salt),氨基-PEG7-C6 (HCl salt) |
147 |
h |
2024-12-23 |
| 83403 |
NH2-PEG8-C6-Cl,3024055-47-5 |
151 |
h |
2024-12-23 |
| 83404 |
NH2-PEG6-C6-Cl,1261350-61-1 |
161 |
h |
2024-12-23 |
| 83405 |
Me-Diazirine-C6-OH,493008-72-3 |
206 |
h |
2024-12-23 |
| 83406 |
Cyanine5-C6-DBCO,2360411-64-7 |
181 |
h |
2024-12-23 |
| 83407 |
Azido-PEG10-C6-Cl,叠氮-PEG10-C6-Cl |
359 |
h |
2024-12-23 |
| 83408 |
Thiol-PEG4-t-butyl ester,564476-33-1 |
157 |
h |
2024-12-23 |
| 83409 |
Amino-PEG12-C6,氨基-PEG12-C6 |
169 |
h |
2024-12-23 |
| 83410 |
Amino-PEG4-C6,3024055-44-2 |
166 |
h |
2024-12-23 |
| 83411 |
Thalidomide-O-C6-acid,2169266-69-5 |
140 |
h |
2024-12-23 |
| 83412 |
NOTA-C6-amine,NOTA-C6-氨基 |
184 |
h |
2024-12-23 |
| 83413 |
Me-Diazirine-C7-OH,1823865-63-9,甲基-双吖丙啶-C7-羟基 |
192 |
h |
2024-12-23 |
| 83414 |
m-PEG12-C11-SH,甲基-十二聚乙二醇-C11-巯基 |
153 |
h |
2024-12-23 |
| 83415 |
m-PEG4-C11-SH,200880-89-3,甲基-四聚乙二醇-C11-巯基 |
188 |
h |
2024-12-23 |
| 83416 |
m-PEG8-C11-SH,甲基-八聚乙二醇-C11-巯基 |
139 |
h |
2024-12-23 |
| 83417 |
(S,R,S)-AHPC-C10-NH2,CAS:2341796-74-3,(S,R,S)-AHPC-C10-胺 |
203 |
h |
2024-12-23 |
| 83418 |
(S,R,S)-AHPC-C9-azide,2906183-84-2,(S,R,S)-AHPC-C9-叠氮 |
180 |
h |
2024-12-23 |
| 83419 |
(S,R,S)-AHPC-C8-azide,2906183-83-1,(S,R,S)-AHPC-C8-叠氮 |
208 |
h |
2024-12-20 |
| 83420 |
m-PEG9-(CH2)8-Phosphonic acid,2900307-00-6,甲基-九聚乙二醇-C8-膦酸 |
173 |
h |
2024-12-20 |
| 83421 |
m-PEG2-(CH2)8-Phosphonic acid,2227008-55-9,甲基-二聚乙二醇-C8-膦酸 |
185 |
h |
2024-12-20 |
| 83422 |
m-PEGn-(CH2)8-Phosphonic acid,甲基-聚乙二醇-C8-膦酸 |
220 |
h |
2024-12-20 |
| 83423 |
Bio-PEG3-C14-鞘氨醇,生物-三聚乙二醇-C14-鞘氨醇 |
235 |
h |
2024-12-20 |
| 83424 |
NHS-C16-COOH,146004-84-4,琥珀酰亚胺酯-C16-酸 |
288 |
h |
2024-12-20 |
| 83425 |
DBCO-CONH-PEG4-Maleimide |
177 |
h |
2024-12-20 |
| 83426 |
cas:2130869-17-7,VCP-Eribulin , ADC试剂 |
186 |
kx |
2024-12-20 |
| 83427 |
cas:452072-20-7,SPP-DM1 ,抗体药物偶联物(ADC) |
195 |
kx |
2024-12-20 |
| 83428 |
1810001-93-4,DBM-MMAF,抗体药物偶联物(ADC) |
230 |
kx |
2024-12-20 |
| 83429 |
Fmoc-Gln(Trt)-PAB-PNP, ADC试剂 |
201 |
kx |
2024-12-20 |
| 83430 |
cas:330970-70-2,Alloc-Val-Ala-OH,((烯丙氧基)羰基)-L-戊基-L-丙氨酸 |
191 |
kx |
2024-12-20 |